MitoPrime NAD+100mg/MOTS-c 10mg/5-Amino-1MQ 10mg
Janoshik
Batch MITO-CA-26F-120
- NAD+
- 99.22 mg
- MOTS-C
- 11.43 mg
- 5-Amino-1-methylquinolinium
- 11.14 mg
NAD+ 100mg/ Mots-C 10mg/ 5-Amino-1mq 10mg
Mitochondrial Blend
Also known as NAD+ 100mg + 5-Amino-1MQ 10mg + MOTS-c 10mg
Mito-Genesis is a research blend supplying NAD+, 5-Amino-1MQ, and MOTS-c in a single vial.
Mix & Match
1 vial — no vial discount yet.
Add 2 more vials for 5% off.
After that, 10% at 5 vials, 20% at 10 vials.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Mito-Genesis is a research blend supplying NAD+, 5-Amino-1MQ, and MOTS-c in a single vial.
Each component is studied separately in mitochondrial and metabolic research; the blend itself has no combined published literature.
Mito-Genesis combines three compounds associated with mitochondrial and metabolic research. NAD+ is a central redox cofactor whose decline is a recurring theme in cellular-ageing work. 5-Amino-1MQ is a small-molecule NNMT inhibitor studied for effects on nicotinamide salvage. MOTS-c is a mitochondrial-derived peptide characterized for metabolic homeostasis and nuclear gene regulation under metabolic stress.
The combination is a formulation choice, not a studied entity. References below are drawn from the component literature.
Each component entered research independently: NAD+ through decades of redox-biology work, 5-Amino-1MQ through NNMT inhibitor screening, and MOTS-c through the discovery of mitochondrial-derived peptides in the 2010s.
Blending them into a single research vial is a supplier formulation with no separate development history.
Research relevant to Mito-Genesis is the sum of its components: mitochondrial-derived peptide signaling, NAD+ redox metabolism, and NNMT inhibition. No study has evaluated this specific three-component combination.
4 of the 4 areas below are addressed directly by a paper cited on this page.
Mitochondrial-derived peptide signaling (MOTS-c)
Addressed on this page by Lee 2015, Kim 2017. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Lee, C. et al. (2015) — The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
- Kim, S.J. et al. (2017) — Mitochondrially derived peptides as novel regulators of metabolism.
NAD+ redox and cellular-ageing models
Addressed on this page by Ying 2006. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Ying, W. (2006) — NAD+ and NADH in cellular functions and cell death.
NNMT inhibition and nicotinamide salvage
Addressed on this page by Cantó 2012, Neelakantan 2017. The work appeared in J Med Chem. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Cantó, C. et al. (2012) — The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.
- Neelakantan, H. et al. (2017) — Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase. J Med Chem 60(13):5015–5028.
Combined metabolic-pathway research frameworks
Addressed on this page by Lee 2015. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Lee, C. et al. (2015) — The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
The references section of this page cites 5 primary papers published between 2006 and 2017 — a limited but non-trivial record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
NAD+ 100mg/ Mots-C 10mg/ 5-Amino-1mq 10mg is frequently listed as a peptide by suppliers in this market. It is not one. The structure published on this page is the compound's actual chemistry, and research on it should be read against its own class rather than against peptide literature.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for NAD+ 100mg/ Mots-C 10mg/ 5-Amino-1mq 10mg, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
NAD+ 100mg/ Mots-C 10mg/ 5-Amino-1mq 10mg is commonly described online in connection with weight loss, appetite suppression and fat reduction. In the research literature the same compound is filed under mitochondrial-derived peptide signaling (MOTS-c), NAD+ redox and cellular-ageing models and NNMT inhibition and nicotinamide salvage.
The 5 papers cited on this page, published between 2006 and 2017 describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
The lot code printed on the vial matches the code on the certificate for NAD+ 100mg/ Mots-C 10mg/ 5-Amino-1mq 10mg. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy NAD+ 100mg/ Mots-C 10mg/ 5-Amino-1mq 10mg in the United States through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
- Lyophilized storage
- −20 °C long-term; stable at room temperature in transit
- After reconstitution
- 2–8 °C
- Light
- Protect from UV and direct light
- Freeze-thaw
- Avoid repeated cycles
- Vehicle
- Solvent selection depends on the compound; consult the published literature
- Format
- Lyophilized powder
NAD+ 100mg/ Mots-C 10mg/ 5-Amino-1mq 10mg is supplied as lyophilized powder. It is not a peptide, and solvent behaviour follows from its own chemistry rather than from the aqueous-vehicle conventions that apply to peptide material — the published literature for this compound is the reference for solvent selection, not a general peptide protocol.
Dry storage below freezing and protection from light are the general controls. As with any lyophilized material, the powder frequently sits as a thin film at the base of the vial and is easy to mistake for an empty vial before inspection.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
- 1 × sealed glass vial in the strength selected (120mg / Single Vial, 120mg / 5-Pack, 120mg / 10-Pack available), batch-labelled
- The batch-linked Certificate of Analysis for the exact lot shipped
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Bacteriostatic water or any other reconstitution vehicle
- Syringes, needles or filters
- Dosing, administration or protocol guidance of any kind
Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of Mito-Genesis. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
PubMedThe NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.
PubMedStructure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase. J Med Chem 60(13):5015–5028.
PubMedRelated
You May Also Like
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$59.99
Wolverine+ is a research blend supplying cartalax, BPC-157, and TB-500 in a single vial.
From$99.99
Coremend is a research blend combining TB-500 (thymosin beta-4 fragment), BPC-157, and the tripeptide KPV in a single preparation, studied for converging tissue-repair and inflammatory-signaling pathways.
From$220.00
Multi-peptide complex studied for collagen signaling, tissue repair pathways, and inflammatory modulation research
From$124.99